Alessandro Bressan - Menarini Ricerche S.p.A

基本信息

浏览量：0

职业迁徙

个人简介

暂无内容

研究兴趣

论文共 24 篇作者统计合作学者相似作者

按年份排序按引用量排序主题筛选期刊级别筛选合作者筛选合作机构筛选

Abstract 665: MEN1703/SEL24 exhibits promising antitumoral activity in preclinical models of myelofibrosis both as single agent and combined with ruxolitinib

Maria Luisa Iannitto,Diego Bisignano,Sonia Zicari, Francesco Belli,Alessio Fiascarelli,Simone Talucci,Giuseppe Merlino, Vittoria Nicolis di Robilant,Clelia Irrissuto,Mario Bigioni,Alessandro Bressan,Daniela Bellarosa,Monica Binaschi

Cancer Researchno. 6_Supplement (2024): 665-665

引用0浏览0引用

Tagraxofusp Shows Promising Anti-Tumoral Efficacy in Preclinical in Vitro Models of Myelofibrosis, Both As a Single Agent and in Combination with Janus Kinase Inhibitors

Maria Luisa Iannitto,Diego Bisignano,Alessio Fiascarelli,Simone Talucci,Sonia Zicari, Francesco Belli,Alessandro Bressan,Christopher Brooks,Daniela Bellarosa,Monica Binaschi

Blood（2023）

引用0浏览0引用

Antitumor Activity of the PI3K Δ-Sparing Inhibitor MEN1611 in PIK3CA Mutated, Trastuzumab-Resistant HER2 + Breast Cancer

Alessio Fiascarelli,Giuseppe Merlino,Stefania Capano,Simone Talucci,Diego Bisignano,Alessandro Bressan,Daniela Bellarosa,Corrado Carrisi,Alessandro Paoli,Mario Bigioni,Patrizia Tunici,Clelia Irrissuto,Massimiliano Salerno,Joaquin Arribas,Elisa de Stanchina,Maurizio Scaltriti,Monica Binaschi

BREAST CANCER RESEARCH AND TREATMENTno. 1 (2023): 13-23

引用1浏览0WOS引用

The Oral SERD Elacestrant in Combination with the PI3K Inhibitor MEN1611 Inhibits Tumor Growth in ER+/HER2-breast Cancer in Vitro and in PDX Models

Giuseppe Merlino,Alessio Fiascarelli,Simone Talucci,Patrizia Tunici,Mario Bigioni,Alessandro Bressan,Monica Binaschi

CANCER RESEARCHno. 7 (2023)

引用0浏览0引用

PIM Inhibition by SEL24/MEN1703 Combines Synergistically with Gilteritinib in FLT3-ITD Preclinical Models of Acute Myeloid Leukemia

Daniela Bellarosa,Sonia Zicari,Giuseppe Merlino,Alessio Fiascarelli,Diego Bisignano, Francesco Belli,Clelia Irrissuto,Simone Talucci,Maria Luisa Iannitto,Mario Bigioni,Alessandro Bressan,Krzysztof Brzozka,Gabriel Ghiaur,Monica Binaschi

Blood（2022）

引用0浏览0引用

Men1611 Is A Pi3k Alpha/Beta Selective And Delta Sparing Inhibitor With Long-Lasting Antitumor Activity In Different Genetic Backgrounds Of Pik3ca Mutant Breast Cancer Models

Alessio Fiascarelli,Corrado Carrisi,Giuseppe Merlino,Stefania Capano,Diego Bisignano,Simone Talucci,Alessandro Bressan, Daniele Bellarosa,Mario Bigioni,Maurizio Scaltriti,Joaquin Arribas,Andrea Pellacani,Massimiliano Salerno,Monica Binaschi

CANCER RESEARCH（2021）

引用0浏览0引用

Dosing Frequency/Pd/Efficacy Relationship Of Men1611 In Her2 Amplified, Pik3ca Mutated, And Refractory To Trastuzumab Xenograft Model Of Breast Cancer

Alessio Fiascarelli,Giuseppe Merlino,Stefania Capano,Alessandro Bressan,Mario Bigioni,Andrea Pellacani,Monica Binaschi,Massimiliano Salerno

CANCER RESEARCH（2021）

引用0浏览0引用

Men1611 promotes immune activating myeloid cell polarization

Stefania Capano,Alessandro Paoli,Alessio Fiascarelli,Andrea Massimiliano Tomirotti,Mario Bigioni,Alessandro Bressan,Daniela Bellarosa,Massimiliano Salerno,Monica Binaschi

CANCER RESEARCH（2021）

引用0浏览0引用

Abstract 1170: MEN1112/OBT357, a First-in-class Humanized De-Fucosylated Monoclonal Antibody Targeting CD157 Positive Cells in Acute Myeloid Leukemia and Myelodysplastic Syndrome

Corrado Carrisi,Daniela Bellarosa,Diego Bisignano,Adriano Venditti,Francesco Buccisano,Giuseppe Sconocchia,Andrea Coppola,Anna Aureli,Alessio Fiascarelli,A. Bressan,Simone Baldini,Andrea Pellacani,Monica Binaschi

Cancer research（2021）

引用0浏览0引用

加载更多

作者统计

合作学者

合作机构

D-Core

合作者
学生
导师

暂无相似学者，你可以通过学者研究领域进行搜索筛选

数据免责声明

页面数据均来自互联网公开来源、合作出版商和通过AI技术自动分析结果，我们不对页面数据的有效性、准确性、正确性、可靠性、完整性和及时性做出任何承诺和保证。若有疑问，可以通过电子邮件方式联系我们：report@aminer.cn